Global Cardiac Arrest Treatment Market Size (2024 - 2029)

Cardiac Arrest Treatment Market Analysis

The cardiac arrest treatment market is expected to register a CAGR of 4.8% over the forecast period.

The outbreak of the pandemic impacted the market. The cancelation of cardiac procedures during COVID-19 adversely impacted the market as it decreased the demand for devices and drugs used in cardiac arrest cases. For instance, according to an NCBI research study published in May 2021, during the COVID-19 pandemic, cardiac procedural activity in England decreased dramatically, with a deficit of about 45,000 procedures, with no increase in the risk of mortality for most cardiac procedures conducted during the pandemic. The same source also stated the negative impact of COVID-19 on cardiology services. Furthermore, according to a PLOS research study published in October 2021, during the pandemic, there was a dramatic drop in referrals and procedures completed for cardiac operations.

Additionally, a European Heart Journal Supplements article published in December 2021 reported that many left atrial appendage occlusion procedures were canceled during the pandemic. However, with the resumption of cardiac procedures amidst declining cases of COVID-19, the market started to gain momentum and is expected to maintain an upward trend over the forecast period.

The increasing prevalence of cardiac diseases and rising geriatric population and the availability of technologically advanced products and reimbursement policies are the major drivers for the market. For instance, according to a research study published in January 2021, the most common cardiac arrhythmia is atrial fibrillation, which is a major risk factor for ischemic stroke and causes an enormous economic burden as well as morbidity and mortality. Furthermore, as per the same source, it is estimated that atrial fibrillation will affect 6 to 12 million people in the United States by 2050, while it will affect 17.9 million people by 2060. This data shows a significant prevalence of atrial fibrillation. Similarly, according to data published by the British Heart Foundation in August 2022, in the United Kingdom, over 7.6 million people lived with heart or circulatory disease in 2021. According to an NCBI research study published in August 2022, cardiovascular diseases were highly prevalent in the rural areas of South Asia, with an incidence of 5.41 per 1,000 person-years as compared to 4.73 per 1,000 person-years in urban areas, and the incidence was higher among males. 

The increasing geriatric population across the globe is also anticipated to propel market growth as older people are more prone to cardiac diseases. For instance, according to the World Population Aging Highlight 2021 report published by the United Nations, the global geriatric population is increasing rapidly around the world, and in 2021, more than 727.0 million people aged 65 years or more were living across the world, which was about 9.3% of the total global population. The same report projected that the population of people aged 65 years or more will be about 1.5 billion people by 2050, which will be about 16.0% of the global population. 

While several factors point to the growth of the market, the lack of advanced healthcare infrastructure, skilled professionals, and highly expensive treatments may restrain the market growth over the forecast period.

Cardiac Arrest Treatment Industry Segmentation

As per the scope of the report, cardiac arrest is an emergency when the heart fails to pump blood effectively and stops beating, when there is a loss of consciousness, and abnormal or absence of breathing in severe cases. The cardiac arrest treatment market is segmented by Treatment (Drugs (Vasopressors, Anti-arrhythmic Drugs, Anticholinergic Drugs, Antihypertensives, and Other Drugs) and Medical Devices (Cardiac Resynchronization Therapy (CRT), Defibrillators, Other Medical Devices)), Distribution Channels (Hospitals, Pharmacies, and Other Distribution Channels), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.